Unknown

Dataset Information

0

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology.


ABSTRACT: BACKGROUND:We previously identified, in newly diagnosed rheumatoid arthritis (RA) patients, networks of co-expressed genes and proteomic biomarkers associated with achieving sustained drug-free remission (sDFR) after treatment with tocilizumab- or methotrexate-based strategies. The aim of this study was to identify, within the same patients, metabolic pathways important for achieving sDFR and to subsequently study the complex interactions between different components of the biological system and how these interactions might affect the therapeutic response in early RA. METHODS:Serum samples were analyzed of 60 patients who participated in the U-Act-Early trial (ClinicalTrials.gov number NCT01034137) and initiated treatment with methotrexate, tocilizumab, or the combination and who were thereafter able to achieve sDFR (n?=?37); as controls, patients were selected who never achieved a drug-free status (n?=?23). Metabolomic measurements were performed using mass spectrometry on oxidative stress, amine, and oxylipin platforms covering various compounds. Partial least square discriminant analyses (PLSDA) were performed to identify, per strategy arm, relevant metabolites of which the biological pathways were studied. In addition, integrative analyses were performed correlating the previously identified transcripts and proteins with the relevant metabolites. RESULTS:In the tocilizumab plus methotrexate, tocilizumab, and methotrexate strategy, respectively, 19, 13, and 12 relevant metabolites were found, which were subsequently used for pathway analyses. The most significant pathway in the tocilizumab plus methotrexate strategy was "histidine metabolism" (p?

SUBMITTER: Teitsma XM 

PROVIDER: S-EPMC6235217 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology.

Teitsma Xavier M XM   Yang Wei W   Jacobs Johannes W G JWG   Pethö-Schramm Attila A   Borm Michelle E A MEA   Harms Amy C AC   Hankemeier Thomas T   van Laar Jacob M JM   Bijlsma Johannes W J JWJ   Lafeber Floris P J G FPJG  

Arthritis research & therapy 20181015 1


<h4>Background</h4>We previously identified, in newly diagnosed rheumatoid arthritis (RA) patients, networks of co-expressed genes and proteomic biomarkers associated with achieving sustained drug-free remission (sDFR) after treatment with tocilizumab- or methotrexate-based strategies. The aim of this study was to identify, within the same patients, metabolic pathways important for achieving sDFR and to subsequently study the complex interactions between different components of the biological sy  ...[more]

Similar Datasets

| S-EPMC5520225 | biostudies-literature
| S-EPMC8251940 | biostudies-literature
| S-EPMC7684730 | biostudies-literature
| S-EPMC10140217 | biostudies-literature
| S-EPMC7011418 | biostudies-literature
| S-EPMC6474583 | biostudies-literature
| S-EPMC7710052 | biostudies-literature
| S-EPMC3946294 | biostudies-literature
| S-EPMC5880849 | biostudies-literature
| S-EPMC4382296 | biostudies-other